Feasibility of a Walking Program for Cancer Survivors Receiving Radiation Therapy (PEDWAY)

May 1, 2017 updated by: Margie McNeely, University of Alberta

Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy

This pilot study will assess whether a supported pedometer-based walking program is helpful in maintaining physical activity for breast and head-and-neck cancer patients who are undergoing radiation therapy. Follow-up monitoring sessions will be scheduled to help provide support for physical activity during radiation therapy. We will also examine the relationship of physical activity and quality of life outcomes to help inform future research.

Study Overview

Status

Completed

Conditions

Detailed Description

Will the integration of a patient-centered exercise prescription and supportive counseling attenuate declines in physical activity during radiation therapy? To address this question, this study will assess the feasibility of a patient-centered walking program for breast and head-and-neck cancer patients undergoing radiation therapy. Follow-up monitoring sessions will be scheduled to help provide support and ongoing counseling to facilitate increased activity (through walking) during radiation therapy. We will also examine the effect of the walking program on other outcomes such as happiness, depression and sleep to determine point estimates and measures of variability to inform future research.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T6J4P9
        • Cross Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Survivors with a diagnosis of breast cancer or head and neck cancer
  • Adults aged 18 years or older
  • Commencing adjuvant radiation therapy treatments
  • Karnofsky Performance Status greater than or equal to 60%

Exclusion Criteria:

  • Clinical or radiological evidence of active disease, either local or metastatic
  • Serious non-malignant disease, such as cardiac failure or advanced arthritis of weight bearing joints, which would preclude daily treatment and follow-up
  • Patients for whom physical activity or exercise is contraindicated
  • Psychiatric or addictive disorders which preclude obtaining informed consent or adherence to the protocol
  • Unable to comply with the protocol, measurement and follow-up schedule (e.g., scheduling conflicts, time commitment)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Walking Intervention
Pedometer Walking Program
All subjects will be prescribed a low-intensity walking program based on their current activity level and an daily assigned step count goal (with the current physical activity recommendations of 30 minutes of moderate-to-vigorous activity per day or 150 minutes per week as the ideal goal). Participants will be provided with face-to-face counseling and written material describing their specific individualized walking program. Participants will also be instructed to maintain their normal activities as much as possible during the intervention period. Participants will be given a pedometer and instructed to wear it at least 5 days per week for the duration of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accrual Rate and Completion Rate
Time Frame: Anticipated duration of radiation therapy of 6 weeks
Accrual: Number of participants agreeing to participate divided by the number of eligible participants Completion rate: number of participants completing the trial
Anticipated duration of radiation therapy of 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: Anticipated duration of radiation therapy of 6 weeks
Adherence to the intervention protocol: number of days meeting target step count
Anticipated duration of radiation therapy of 6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-Minute Walk Test
Time Frame: Change from baseline to anticipated end of radiation therapy of 6 weeks
The six-minute walk test (6MWT) measures the distance an individual is able to walk over a six minutes time period on a hard, flat surface (e.g., 100 foot hallway).
Change from baseline to anticipated end of radiation therapy of 6 weeks
Physical Activity
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
An accelerometer armband will be used to provide a breakdown of an individual's daily activity.
Change from baseline to anticipated duration of radiation therapy of 6 weeks
Self-esteem
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
Rosenberg Self-Esteem Scale (10 item)
Change from baseline to anticipated duration of radiation therapy of 6 weeks
Depression
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
Beck Depression Inventory II (21 item)
Change from baseline to anticipated duration of radiation therapy of 6 weeks
Happiness
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
Oxford Happiness Questionnaire (29 items)
Change from baseline to anticipated duration of radiation therapy of 6 weeks
Sleep
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
Pittsburgh Sleep Quality Index (9 item)
Change from baseline to anticipated duration of radiation therapy of 6 weeks
Fatigue
Time Frame: Recorded daily during study period of 6 weeks
Visual analogue scale, recorded as part of daily diary
Recorded daily during study period of 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margaret McNeely, PhD, University of Alberta and Cross Cancer Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

June 16, 2013

First Submitted That Met QC Criteria

June 25, 2013

First Posted (Estimate)

June 26, 2013

Study Record Updates

Last Update Posted (Actual)

May 3, 2017

Last Update Submitted That Met QC Criteria

May 1, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

No plan in place

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Pedometer Walking Program

3
Subscribe